# Symptom Management in Palliative Care

## Common Symptoms Overview

### Fatigue and Weakness
**Assessment**: Use 0-10 scale (ESAS), functional impact assessment
- **Causes**: Cancer, treatment effects, anemia, depression, poor nutrition
- **Management**: 
  - Energy conservation techniques
  - Gentle exercise (as tolerated)
  - Treat reversible causes (anemia, thyroid, depression)
  - Psychostimulants (methylphenidate 5-10mg BID) if appropriate

### Nausea and Vomiting
**Assessment**: Timing, triggers, associated symptoms
- **Acute**: Ondansetron 4-8mg q8h PO/IV/SL
- **Delayed/Chronic**: Metoclopramide 10mg q6h PO
- **Anticipatory**: Lorazepam 0.5-1mg SL pre-treatment
- **Refractory**: Olanzapine 2.5-5mg daily

### Dyspnea
**Assessment**: Rest vs. exertional, onset, severity (0-10 scale)
- **Non-pharmacological**: Fan, positioning, breathing techniques
- **Opioids**: Morphine 2.5-5mg q4h PO (opioid-naive)
- **Anxiolytic**: Lorazepam 0.5-1mg SL if anxiety component
- **Oxygen**: Only if hypoxic (SpO2 <90%)

### Delirium
**Assessment**: CAM (Confusion Assessment Method), precipitants
- **Hyperactive**: Haloperidol 0.5-1mg q2-4h PRN
- **Hypoactive**: Address reversible causes, environmental modifications
- **Mixed**: Quetiapine 12.5-25mg BID
- **Terminal**: Consider comfort-focused approach

### Depression and Anxiety
**Assessment**: PHQ-9, GAD-7, clinical interview
- **Mild-Moderate**: Counseling, SSRI (sertraline 25-50mg daily)
- **Severe**: Psychiatry referral, consider mirtazapine 15-30mg HS
- **Anxiety**: Lorazepam 0.5-1mg q6h PRN, buspirone for chronic

### Constipation
**Assessment**: Frequency, consistency (Bristol scale), associated symptoms
- **Prevention**: Docusate 100mg BID + senna 2 tabs HS
- **Treatment**: Add bisacodyl 10mg daily, consider lactulose
- **Refractory**: Methylnaltrexone, manual disimpaction

### Loss of Appetite
**Assessment**: Nutritional status, cachexia signs
- **Appetite stimulants**: Megestrol 400-800mg daily, dexamethasone 2-4mg daily
- **Nutritional support**: Small frequent meals, high-calorie supplements
- **Cachexia**: Consider corticosteroids, address family concerns

## Assessment Tools

### Edmonton Symptom Assessment System (ESAS)
- **Symptoms**: Pain, fatigue, nausea, depression, anxiety, drowsiness, appetite, wellbeing, dyspnea, other
- **Scale**: 0-10 for each symptom
- **Frequency**: Daily in acute settings, weekly in outpatient
- **Action**: Score â‰¥4 requires intervention

### Performance Status Scales
- **ECOG**: 0 (normal) to 4 (bedridden)
- **Karnofsky**: 0-100% functional capacity
- **PPS (Palliative)**: 0-100% with ambulation, activity, self-care, intake, consciousness

### Quality of Life Measures
- **EORTC QLQ-C30**: Cancer-specific quality of life
- **FACIT-PAL**: Palliative care quality of life
- **McGill QOL**: Existential and spiritual domains

## Treatment Algorithms

### Stepwise Symptom Management
1. **Assess**: Comprehensive symptom assessment
2. **Identify**: Reversible vs. irreversible causes
3. **Treat**: Address underlying causes when appropriate
4. **Palliate**: Symptomatic management for irreversible symptoms
5. **Monitor**: Regular reassessment and adjustment
6. **Communicate**: Goals of care and expectations

### Non-pharmacological Interventions
- **Physical**: Positioning, mobility aids, physiotherapy
- **Psychological**: Counseling, relaxation techniques, meditation
- **Social**: Family support, peer groups, chaplaincy
- **Environmental**: Temperature, lighting, noise control

### Medication Guidelines
- **Start low, go slow**: Especially in elderly or frail patients
- **Regular review**: Discontinue ineffective medications
- **Drug interactions**: Consider polypharmacy effects
- **Routes**: Oral preferred, alternatives when needed (SL, PR, SC, IV)

## Monitoring Guidelines

### Frequency of Assessment
- **Inpatient**: Daily symptom screening
- **Outpatient**: Weekly during active management
- **Stable**: Monthly or as clinically indicated
- **Crisis**: Continuous monitoring with rapid response

### Documentation Requirements
- **Symptom scores**: Baseline and trend data
- **Response to treatment**: Effectiveness and side effects
- **Functional impact**: Activities of daily living
- **Goals of care**: Patient and family preferences

### When to Escalate Care
- **Refractory symptoms**: No response to standard treatment
- **Rapid deterioration**: Sudden change in status
- **Complex needs**: Multiple symptoms requiring coordination
- **Family distress**: Caregiver burden or conflict

### Interdisciplinary Communication
- **Daily rounds**: Team coordination
- **Family meetings**: Goals clarification
- **Care transitions**: Handoff communication
- **Documentation**: Shared care plans and updates

_[Return to Table of Contents](../toc.md)_
